Akebia Therapeutics Inc (AKBA) ニュース

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire CAMBRIDGE...

Akebia Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Akebia Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference PR Newswire CAMBRIDGE...

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire CAMBRIDGE...

U.S. Renal Care Enrolled First Patients in the VOICE Collaborative Clinical Trial of Vafseo® (vadadustat) for CKD Patients on Dialysis

U.S. Renal Care Enrolled First Patients in the VOICE Collaborative Clinical Trial of Vafseo® (vadadustat) for...

Akebia Therapeutics to Present at the 36th Annual Piper Sandler Healthcare Conference

Akebia Therapeutics to Present at the 36th Annual Piper Sandler Healthcare Conference PR Newswire CAMBRIDGE...

Vadadustat Alternative Dosing Study Results Published in the American Journal of Kidney Disease

Vadadustat Alternative Dosing Study Results Published in the American Journal of Kidney Disease PR...

Akebia Therapeutics to Present at the Jefferies London Healthcare Conference

Akebia Therapeutics to Present at the Jefferies London Healthcare Conference PR Newswire CAMBRIDGE, Mass...

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Akebia Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights

Akebia Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights PR...

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire CAMBRIDGE...

Akebia Therapeutics to Report Third Quarter 2024 Financial Results and Discuss Recent Business Highlights

Akebia Therapeutics to Report Third Quarter 2024 Financial Results and Discuss Recent Business Highlights PR...

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Form 8-K - Current report